Answers are grounded in this paper and cite their sources.
= 0.04). CSF levels of Aβ1-42 could be used as a complementary tool to ALS diagnosis, and total Tau and phospho-Tau levels may help establishing the prognosis of ALS. Further studies merit exploring the pathophysiological mechanisms associated with these markers. Despite their lack of specificity, phospho-Tau/total Tau and Aβ1-42 should be combined to other biological and clinical markers in order to improve ALS management.
No takes yet. Share an insight, caveat, or question.
Lanznaster et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: